Aquestive Therapeutics (AQST)
(Delayed Data from NSDQ)
$3.93 USD
+0.03 (0.77%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $3.92 -0.01 (-0.25%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/07/2024
Time: -- |
3/2024 | $-0.09 | -17.42% |
Earnings Summary
For their last quarter, Aquestive Therapeutics (AQST) reported earnings of -$0.12 per share, missing the Zacks Consensus Estimate of -$0.08 per share. This reflects a negative earnings surprise of 50.00%. Look out for AQST's next earnings release expected on May 07, 2024. For the next earning release, we expect the company to report earnings of -$0.09 per share, reflecting a year-over-year decrease of 181.82%.
Earnings History
Price & Consensus
Zacks News for AQST
Aquestive Therapeutics (AQST) Flat As Market Sinks: What You Should Know
AQST: What are Zacks experts saying now?
Zacks Private Portfolio Services